Cmg Pharmaceutical Co., Ltd. logo

Cmg Pharmaceutical Co., Ltd. (058820)

Market Open
30 Sep, 06:30 AM
KRX SM KRX SM
₩
562. 00
0
0%
₩
213.63B Market Cap
- P/E Ratio
- Div Yield
689,859 Volume
- Eps
₩ 562
Previous Close
Add Transaction
Day Range
562 562
Year Range
526 2,205
Want to track 058820 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 058820 split of 1:10 in 11 days (27 Oct 2026)

Cmg Pharmaceutical Co., Ltd. (058820) Statistics

Valuation metrics

Market Cap 213.63B
Enterprise value 140.28B
Trailing P/E (ttm) 14.34
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 0.72
Price/Book (mrq) 0.41
Enterprise Value/Revenue 1.21
Enterprise Value/EBITDA 33.42

Overview

Shares outstanding 147.84M
Float 110M
Shares short -
% Held by insiders 0.24%
% Held by institutions 0.01%
Average volume (10 days) 114.98K
Average volume (90 days) 926.78K

Price summary

52-Week low 526
52-Week high 2,205
Beta 0.59
50-Day moving average 575.72
200-Day moving average 1,080.68

Dividends and splits

Forward annual dividend rate 23.06
Forward annual dividend yield 0.016%
Trailing annual dividend rate 23.96
Trailing annual dividend yield 0.0166%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,073:1,000
Last split Date 13 Jun 2019

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.05%
Operating margin -0.03%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.03%

Income Statement

Revenue (ttm) 105.23B
Revenue per share (ttm) 782.31
Quarterly revenue growth (yoy) 0.18%
Gross profit (ttm) 60.88B
EBITDA -610.42M
Net income to common (ttm) -10.08B
Diluted EPS (ttm) 38.9
Quarterly earnings growth (yoy) 0.24%

Balance Sheet

Total cash (mrq) 26.5B
Total cash per share (mrq) 119.98
Total debt (mrq) 72.01B
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 1.17%
Book value per share (mrq) 1,381.28

Cash Flow

Cash flow statement -11.02B
Levered free cash flow (LFCF) -42.98B